BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 25, 2026
Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Prostate cancer therapies in the spotlight at AUA meeting

April 30, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Diagnostics & Imaging Week)
Read More

Prostate cancer therapies in the spotlight at AUA meeting

April 29, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Medical Device Daily)
Read More

Study shows costs improve for DES vs. surgery for some patients

April 1, 2009
By Larry Haimovitch
ORLANDO — With a massive number of clinical trial data being reported here the past few days, winnowing out the most important ones became a major challenge. However, one trial that stood out from the crowd because of its focus on quality of life (QOL) and healthcare cost outcomes was the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial. (Medical Device Daily)
Read More

Watchman shown to be better than warfarin for non-valvular AF

March 31, 2009
By Larry Haimovitch
ORLANDO — The 58th annual scientific session of the American College of Cardiology (ACC; Bethesda, Maryland) kicked off here early on Saturday morning with a session devoted to "Late Breaking Clinical Trials." (Medical Device Daily)
Read More

AFib seen as a hot sector for new technology developments

March 11, 2009
By Larry Haimovitch

Macular degeneration remains a key topic for retinal specialists

March 1, 2009
By Larry Haimovitch

Despite missing its endpoint, NEST-2 trial shows promise

Feb. 24, 2009
By Larry Haimovitch

Macular degeneration a key topic for retinal specialists

Jan. 28, 2009
By Larry Haimovitch
WAILEA MAUI, Hawaii – The annual Hawaiian Eye Meeting was held here last week at the Grand Wailea Resort as specialists from three key ophthalmic specialties – cataract, refractive and retinal surgery – gathered to hear the latest clinical information and to enjoy the sunny and warm weather. (Medical Device Daily)
Read More

Big proposed deal sharpens focus on ophthalmology space

Jan. 21, 2009
By Larry Haimovitch

Economy roils sector, but big players cite some positive signs

Jan. 1, 2009
By Larry Haimovitch
Previous 1 2 … 5 6 7 8 9 10 11 12 13 … 18 19 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Roche reports new TREM2 agonists

    BioWorld Science
    F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
  • Brain and DNA

    Sangamo presents primate data for prion suppressor ST-506

    BioWorld Science
    Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
  • Genescience presents STAT6 degrader for atopic dermatitis

    BioWorld Science
    Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing